Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Lescoat

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 18, 2019
Interstitial Lung Disease and Mediastinal Lymph Nodes: A Computed Tomography-based Biomarker beyond Nosological and Etiological Borders?Alain Lescoat, Mathieu Lederlin, Alice Ballerie, et al.
Medical Education|January 21, 2026
'I was a bit hasty … I was a young resident!' Medical residents' responses to clinical uncertaintyNicolas Belhomme, Alain Lescoat, Pierre Pottier, et al.
Seminars in Arthritis and Rheumatism|December 29, 2022
Should we really include systemic sclerosis specific antibodies in the classification criteria of Sjogren's disease?François Zimmermann, François Robin, Simon Cadiou, et al.
Annals of the Rheumatic Diseases|October 1, 2018
M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosisAlain Lescoat, Alice Ballerie, Stephane Jouneau, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 3, 2025
Venous thromboembolic events in patients treated with Janus kinase inhibitors for atopic dermatitisCatherine Droitcourt, Sandrine Kerbrat, Delphine Staumont-Salle, et al.
Autoimmunity Reviews|March 14, 2023
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for cliniciansShiri Keret, Doron Rimar, Pauline Lansiaux, et al.
Journal of Clinical Medicine|January 8, 2025
Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome CriteriaMarion Mercier, Alain Lescoat, Morgane Pierre-Jean, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 18, 2026
Prognostic Value of Combining Serum Tryptase and Bone Mineral Density in Predicting Fractures in Systemic MastocytosisFrançois Robin, Victoria Bureau, Antoine Vivier, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 9, 2020
Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicityKarima Alim, Arnaud Bruyère, Alain Lescoat, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2022
Patient-reported outcomes and their relation with iron parameters in HFE haemochromatosis during maintenance therapy: A prospective cohort studyNicolas Belhomme, Jeff Morcet, Alain Lescoat, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
American Journal of Respiratory and Critical Care Medicine|January 18, 2019
Interstitial Lung Disease and Mediastinal Lymph Nodes: A Computed Tomography-based Biomarker beyond Nosological and Etiological Borders?Alain Lescoat, Mathieu Lederlin, Alice Ballerie, et al.
Medical Education|January 21, 2026
'I was a bit hasty … I was a young resident!' Medical residents' responses to clinical uncertaintyNicolas Belhomme, Alain Lescoat, Pierre Pottier, et al.
Seminars in Arthritis and Rheumatism|December 29, 2022
Should we really include systemic sclerosis specific antibodies in the classification criteria of Sjogren's disease?François Zimmermann, François Robin, Simon Cadiou, et al.
Annals of the Rheumatic Diseases|October 1, 2018
M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosisAlain Lescoat, Alice Ballerie, Stephane Jouneau, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 3, 2025
Venous thromboembolic events in patients treated with Janus kinase inhibitors for atopic dermatitisCatherine Droitcourt, Sandrine Kerbrat, Delphine Staumont-Salle, et al.
Autoimmunity Reviews|March 14, 2023
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for cliniciansShiri Keret, Doron Rimar, Pauline Lansiaux, et al.
Journal of Clinical Medicine|January 8, 2025
Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome CriteriaMarion Mercier, Alain Lescoat, Morgane Pierre-Jean, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 18, 2026
Prognostic Value of Combining Serum Tryptase and Bone Mineral Density in Predicting Fractures in Systemic MastocytosisFrançois Robin, Victoria Bureau, Antoine Vivier, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 9, 2020
Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicityKarima Alim, Arnaud Bruyère, Alain Lescoat, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2022
Patient-reported outcomes and their relation with iron parameters in HFE haemochromatosis during maintenance therapy: A prospective cohort studyNicolas Belhomme, Jeff Morcet, Alain Lescoat, et al.
Pageof 15